Special Issue "Vaccine Research against Significant Viral Diseases of Poultry"
Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 21405
Interests: veterinary diagnostics; veterinary virology; molecular biology; next-generation sequencing; vaccine development
Special Issues, Collections and Topics in MDPI journals
We are soliciting articles for this Special Issue of MDPI Vaccines, which is titled “Vaccine Research against Significant Viral Diseases of Poultry”.
The global poultry industry accounts for the production of over 115 million metric tons of meat and eggs. By 2030, the world is anticipated to need food for more than eight billion people. Due to the growing world population and increased protein consumption demand, it is projected that poultry production will increase by 25% during the next decade. In many developing countries, poultry is the main source of protein and income in rural areas. Some viral poultry diseases such as (but not limited to) avian influenza, infectious bronchitis, infectious laryngthracheitis, Marek’s disease, Newcastle disease, and reoviral arthritis are of great economic and social importance. Such diseases are controlled through vaccination and strict biosecurity, and in many countries, some are contained using stamping out. However, due to the continuing evolution of some of these viruses and emergence of new virulent variants, vaccination has not always been fully effective. For others, such as infectious laryngothracheitis and reoviral infections, vaccine development is challenging. Vaccines and vaccination programs need to be constantly updated, and the development of new vaccination strategies continues to be a topic of interest to the field.
Given this background, this Special Issue of Vaccines aims to highlight recent advances in vaccine development for avian viral disease and associated challenges. The issue welcomes research articles, reviews, and short communications on topics including, but not limited to, the generation of vaccines against avian viral diseases; novel approaches to elicit protective innate, humoral, and cellular responses; the induction of neutralizing antibodies and their roles in protection; vectored and recombinant vaccine approaches; and advances in vaccine adjuvants.
Dr. Kiril Dimitrov
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- immune response